ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms

New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response

(2018) Klaudia Szymonowicz et al.   Cancers

PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools

(2018) Huaiyu Mi et al.   NUCLEIC ACIDS RESEARCH

Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1–associated, and radiation-associated malignant peripheral nerve sheath tumors

(2017) Kelsey L. Watson et al.   JOURNAL OF NEUROSURGERY

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)

(2016) T. Valentin et al.   EUROPEAN JOURNAL OF CANCER

Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells

(2015) Nicole M. Brossier et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Upon oxidative stress, the antiapoptotic Hsp60/procaspase-3 complex persists in mucoepidermoid carcinoma cells

(2015) C Campanella et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

(2014) T. Nakaoku et al.   CLINICAL CANCER RESEARCH

Different immunohistochemical levels of Hsp60 and Hsp70 in a subset of brain tumors and putative role of Hsp60 in neuroepithelial tumorigenesis

(2014) F. Rappa et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration

(2014) Wen Zhu et al.   Molecular Cancer

YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma

(2014) Jian Kong et al.   Molecular Cancer

A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance

(2014) J. Xia et al.   MOLECULAR CANCER THERAPEUTICS

Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors

(2014) Ming Zhang et al.   NATURE GENETICS

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

(2014) William Lee et al.   NATURE GENETICS

Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis

(2013) Stephanie N. Brosius et al.   ACTA NEUROPATHOLOGICA

Transgenic Mice Overexpressing Neuregulin-1 Model Neurofibroma-Malignant Peripheral Nerve Sheath Tumor Progression and Implicate Specific Chromosomal Copy Number Variations in Tumorigenesis

(2013) Syed J. Kazmi et al.   AMERICAN JOURNAL OF PATHOLOGY

Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread

(2013) Sabrina Daniela Silva et al.   CLINICAL & EXPERIMENTAL METASTASIS

Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor

(2013) Q. Fan et al.   Clinical & Translational Oncology

CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro

(2013) Ilkka Paatero et al.   GYNECOLOGIC ONCOLOGY

Malignant Peripheral Nerve Sheath Tumor Invasion Requires Aberrantly Expressed EGF Receptors and Is Variably Enhanced by Multiple EGF Family Ligands

(2013) Stephanie J. Byer et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Oncologic Outcomes of Sporadic, Neurofibromatosis-Associated, and Radiation-Induced Malignant Peripheral Nerve Sheath Tumors

(2012) Jennifer LaFemina et al.   ANNALS OF SURGICAL ONCOLOGY

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1

(2012) M. Kolberg et al.   NEURO-ONCOLOGY

Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms

(2011) Steven L. Carroll   ACTA NEUROPATHOLOGICA

Malignant Peripheral Nerve Sheath Tumors (MPNST): The Mayo Clinic Experience

(2011) Chee-Chee H. Stucky et al.   ANNALS OF SURGICAL ONCOLOGY

Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines

(2011) Estefanía Carrasco-García et al.   EXPERIMENTAL CELL RESEARCH

Receptor tyrosine kinases and their activation in melanoma

(2011) David J. Easty et al.   Pigment Cell & Melanoma Research

WNK1 is required for mitosis and abscission

(2011) S.-w. Tu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

(2011) Amy N. Turk et al.   Jove-Journal of Visualized Experiments

Transcription Factor Stat3 Stimulates Metastatic Behavior of Human Prostate Cancer Cells in Vivo, whereas Stat5b Has a Preferential Role in the Promotion of Prostate Cancer Cell Viability and Tumor Growth

(2010) Lei Gu et al.   AMERICAN JOURNAL OF PATHOLOGY

Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

(2010) Lei Gu et al.   ENDOCRINE-RELATED CANCER

Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner

(2010) S. J. Byer et al.   NEURO-ONCOLOGY

Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome

(2009) Changye Zou et al.   ANNALS OF SURGERY

Neuregulin-1β and neuregulin-1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells

(2009) Jenell M. Eckert et al.   GLIA